<DOC>
	<DOCNO>NCT01974336</DOCNO>
	<brief_summary>The efficacy UDCA treat parenteral nutrition-associated cholestasis ( PNAC ) identify study child without short bowel syndrome ( SBS ) .Most adult suffer PNAC SBS . limit potential function UDCA lack SBS patient malabsorption UDCA.Therefore , design clinical trial center SBS approach preventative therapeutical effect UDCA PNAC adult short bowel syndrome .</brief_summary>
	<brief_title>The Preventative Therapeutical Effect Ursodeoxycholic Acid ( UDCA ) Short Bowel Syndrome Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Patients short bowel syndrome support total parenteral nutrition . Patients intestine 50cm . Requirements informed consent assent participant , parent legal guardian applicable Consciousness ability cooperate . Patients obstruction biliary tract , infection , autoimmune disease , cancer Patients intestine le 50cm A clinically significant laboratory abnormality history significant cardiac , pulmonary , hepatic , renal disease Female positive pregnancy Allergy ursodeoxycholic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>